New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 25, 2013
05:13 EDTRDYDr. Reddy's announces the launch of Desloratadine ODT
Dr. Reddy's Laboratories announced that it has launched Desloratadine Orally Disintegrating Tablets, or ODT, a bioequivalent generic version of Clarinex Reditabs in the US market on January 24. Dr. Reddy's ANDA for Desloratadine ODT is approved by the FDA. The Clarinex Reditabs brand had U.S. sales of approximately $5.3M for the most recent twelve months ending November 2012, according to IMS Health.
News For RDY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
12:11 EDTRDYDr. Reddy's Labs downgraded to Neutral from Buy at UBS
Subscribe for More Information
06:50 EDTRDYDr. Reddy's Labs reports Q1 Global Generics revenue Rs 31B
Reports Q1 Pharmaceutical Services and Active Ingredients revenue Rs 5.6B.
06:50 EDTRDYDr. Reddy's Labs reports Q1 EPS 58c vs. 51c last year
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use